These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10166759)

  • 21. Incorporating HIV education and counseling into routine prenatal care: a program model.
    Mason J; Preisinger J; Sperling R; Walther V; Berrier J; Evans V
    AIDS Educ Prev; 1991; 3(2):118-23. PubMed ID: 1873135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A preliminary comparison of major kinds of obstacles to enrolling in substance abuse treatment (AOD) reported by injecting street outreach clients and other stakeholders.
    Appel PW; Oldak R
    Am J Drug Alcohol Abuse; 2007; 33(5):699-705. PubMed ID: 17891662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights from a national survey into why substance abuse treatment units add prevention and outreach services.
    Wells R; Lemak CH; D'Aunno TA
    Subst Abuse Treat Prev Policy; 2006 Aug; 1():21. PubMed ID: 16887037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [4-year experience of the Lund model for HIV/AIDS prevention. Needle-exchange program as a bridge to continued care of drug addicts].
    Tunving K; Nyholm K
    Lakartidningen; 1991 May; 88(19):1797, 1799. PubMed ID: 2041431
    [No Abstract]   [Full Text] [Related]  

  • 27. Do licensing and accreditation matter in outpatient substance abuse treatment programs?
    Wells R; Lemak CH; Alexander JA; Nahra TA; Ye Y; Campbell CI
    J Subst Abuse Treat; 2007 Jul; 33(1):43-50. PubMed ID: 17588488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AIDS prevention.
    Addiction; 1993 Jan; 88(1):146. PubMed ID: 8448506
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment for substance abuse in Australia: a comparison of public and private programs.
    McNeese-Smith DK
    Int J Psychiatr Nurs Res; 2003 Sep; 9(1):1025-38. PubMed ID: 14533233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of HIV prevention interventions with people living with HIV/AIDS in clinical settings: challenges and lessons learned.
    Koester KA; Maiorana A; Vernon K; Myers J; Rose CD; Morin S
    AIDS Behav; 2007 Sep; 11(5 Suppl):S17-29. PubMed ID: 17436072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of an AIDS prevention education program for health service providers working with i.v. drug users.
    Nelson FL; Kabacy M
    J Subst Abuse; 1989; 1(4):467-70. PubMed ID: 2485292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital care for drug users with AIDS or HIV infection in France.
    Lert F; Marne MJ
    AIDS Care; 1992; 4(3):333-8. PubMed ID: 1525204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cultural competence in outpatient substance abuse treatment: measurement and relationship to wait time and retention.
    Guerrero E; Andrews CM
    Drug Alcohol Depend; 2011 Dec; 119(1-2):e13-22. PubMed ID: 21680111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units.
    Strauss SM; Astone JM; Des Jarlais DC; Hagan H
    AIDS Patient Care STDS; 2005 Feb; 19(2):78-88. PubMed ID: 15716639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug treatment staff attitudes toward AIDS and workplace transmission of HIV: a survey and follow-up--Spectrum House, Inc.
    Connors MM; Lewis BF; Russo JP; Baker LA
    J Subst Abuse Treat; 1991; 8(4):297-302. PubMed ID: 1664868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in managed care activity in outpatient substance abuse treatment organizations, 1995-2000.
    Alexander JA; Lemak CH; Campbell CI
    J Behav Health Serv Res; 2003; 30(4):369-81. PubMed ID: 14593661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors that influence staffing of outpatient substance abuse treatment programs.
    Lemak CH; Alexander JA
    Psychiatr Serv; 2005 Aug; 56(8):934-9. PubMed ID: 16088009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health services for women in outpatient substance abuse treatment.
    Campbell CI; Alexander JA
    Health Serv Res; 2005 Jun; 40(3):781-810. PubMed ID: 15960691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modifying the process of treatment to meet the threat of AIDS.
    Brown BS; Needle RH
    Int J Addict; 1994 Nov; 29(13):1739-52. PubMed ID: 7852000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Availability of services for women in outpatient substance abuse treatment: 1995-2000.
    Campbell CI; Alexander JA
    J Behav Health Serv Res; 2006 Jan; 33(1):1-19. PubMed ID: 16636905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.